ARTICLE | Company News
Caprion, Boehringer Ingelheim deal
July 18, 2005 7:00 AM UTC
The companies partnered to use Caprion's CellCarta proteomics discovery technology to identify biomarkers of metabolic and inflammatory diseases. Financial terms were not disclosed. ...